Skip to Main Content

Author Details

Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
2000
121
43
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37875568Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population.Nat Med2024
38056114Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity.J Clin Virol2024
38048277A Flexible, Quantitative Plasmonic-Fluor Lateral Flow Assay for the Rapid Detection of <i>Orthoebolavirus zairense</i> and <i>Orthoebolavirus sudanense</i>.ACS Infect Dis2024
36652990Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population.Nat Med2023
37613387The Ebola NP0VP35 Complex Phase Separates into Inclusion Body-Like Structures.Microsc Microanal2023
37787461Elevated Level of Circulating but Not Urine S100A8/A9 Identifies Poor COVID-19 Outcomes.ACS Infect Dis2023
37832991Host entry factors of Rift Valley Fever Virus infection.Adv Virus Res2023
37598728Disruption of Ebola NP<sup>0</sup>VP35 Inclusion Body-like Structures reduce Viral Infection.J Mol Biol2023
37450601Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice.Sci Adv2023
37243162Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.Viruses2023
37205707Biochemical and HDX Mass Spectral Characterization of the SARS-CoV-2 Nsp1 Protein.Biochemistry2023
35193958Multiple genetic paths including massive gene amplification allow <i>Mycobacterium tuberculosis</i> to overcome loss of ESX-3 secretion system substrates.Proc Natl Acad Sci U S A2022
35709511Liquid Phase Partitioning in Virus Replication: Observations and Opportunities.Annu Rev Virol2022
35477718A cryptic pocket in Ebola VP35 allosterically controls RNA binding.Nat Commun2022
35405107Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins.J Mol Biol2022
35730685Antigenic landscapes on <i>Staphylococcus aureus</i> pore-forming toxins reveal insights into specificity and cross-neutralization.MAbs2022
35536005Human Metapneumovirus Phosphoprotein Independently Drives Phase Separation and Recruits Nucleoprotein to Liquid-Like Bodies.mBio2022
35831295The intrinsically disordered protein TgIST from Toxoplasma gondii inhibits STAT1 signaling by blocking cofactor recruitment.Nat Commun2022
35761082LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition.Nat Immunol2022
35789908Monoclonal antibodies binding data for SARS-CoV-2 proteins.Data Brief2022
35784644Rapid detection of an Ebola biomarker with optical microring resonators.Cell Rep Methods2022
35618731SARS-CoV-2 accessory proteins reveal distinct serological signatures in children.Nat Commun2022
36548304Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active site.PLoS Pathog2022
35939689Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1.Proc Natl Acad Sci U S A2022
35867632Plasmonic Fluor-Enhanced Antigen Arrays for High-Throughput, Serological Studies of SARS-CoV-2.ACS Infect Dis2022
36194021Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.J Virol2022
36153732Detection of biomarkers for filoviral infection with a silicon photonic resonator platform.STAR Protoc2022
35026950Nipah Virus V Protein Binding Alters MDA5 Helicase Folding Dynamics.ACS Infect Dis2022
34329642Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.J Mol Biol2021
33649232Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.Proc Natl Acad Sci U S A2021
33691097Itaconate confers tolerance to late NLRP3 inflammasome activation.Cell Rep2021
34977676Cryo-EM analysis of Ebola virus nucleocapsid-like assembly.STAR Protoc2021
34644581Nuclear-localized human respiratory syncytial virus NS1 protein modulates host gene transcription.Cell Rep2021
34642671Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein.STAR Protoc2021
344638772021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2021
34559985Lrp1 is a host entry factor for Rift Valley fever virus.Cell2021
34095780Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain.iScience2021
34260076Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection.EMBO J2021
31562565Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription.Cell Mol Life Sci2020
31899866Small Molecule Compounds That Inhibit Antioxidant Response Gene Expression in an Inducer-Dependent Manner.ACS Infect Dis2020
31914382The Cap-Snatching SFTSV Endonuclease Domain Is an Antiviral Target.Cell Rep2020
33398270Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.bioRxiv2020
328880502020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales.Arch Virol2020
32714117Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.SSRN2020
32735849Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.Cell Host Microbe2020
32446802Fragment screening targeting Ebola virus nucleoprotein C-terminal domain identifies lead candidates.Antiviral Res2020
32511401Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.bioRxiv2020
30663023Taxonomy of the order Mononegavirales: second update 2018.Arch Virol2019
31130511A Secreted Viral Nonstructural Protein Determines Intestinal Norovirus Pathogenesis.Cell Host Microbe2019
31155428Ebola Virus Replication Stands Out.Trends Microbiol2019
  • 1 - 50 of 121

Recommended Authors

Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 7
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 7
Stuart Weston
University of Maryland School of Medicine
Career Start Year 2014
Number of shared co-authors 9
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 3
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 6
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 11
Xuping Xie
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 9
Maria Teresa S??nchez-Aparicio
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 7
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 6
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 4
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 1
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 16
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 9
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 4
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 0
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 3
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 4
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 6
Priya S Shah
University of California davis
Career Start Year 2002
Number of shared co-authors 6
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 9
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 10
Ian Goodfellow
University of Cambridge
Career Start Year 1996
Number of shared co-authors 4
Abraham L Brass
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 4
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 1
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 12
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 4
Raul Andino
University of California san francisco
Career Start Year 1981
Number of shared co-authors 10
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 10
David I Stuart
University of Oxford
Career Start Year 1976
Number of shared co-authors 2
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 9

Collaborators

Daisy W Leung
Washington University School of Medicine
Co-authored papers 69
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Co-authored papers 50
Michael L Gross
Washington University in St. Louis
Co-authored papers 16
Elke Mühlberger
Co-authored papers 11
Priya Luthra
Trudeau Institute
Co-authored papers 11
Sina Bavari
Co-authored papers 10
Sachdev S Sidhu
School of Pharmacy, University of Waterloo
Co-authored papers 10
Gary P Kobinger
University of Texas Medical Branch
Co-authored papers 9
Jens H Kuhn
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 9
Janusz T Paweska
University of Pretoria
Co-authored papers 9
Michael S Diamond
Washington University School of Medicine
Co-authored papers 8
Jennifer M Binning
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 8
Robert A Davey
Boston University
Co-authored papers 7
Martin Schwemmle
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers 6
Nawneet Mishra
Washington University School of Medicine in St. Louis
Co-authored papers 6
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Maxim N Artyomov
Co-authored papers 5
Rita E Chen
Co-authored papers 5
Elodie Ghedin
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 5
Ian Crozier
Christchurch Hospital
Co-authored papers 4
Manu Anantpadma
Boston University
Co-authored papers 4
Elitza S Theel
Division of Clinical Microbiology, Mayo Clinic
Co-authored papers 3
Wah Chiu
Stanford University
Co-authored papers 3
John L Markley
University of Wisconsin-Madison
Co-authored papers 3
Michael K Rosen
UT Southwestern Medical Center
Co-authored papers 3
Jyoti Batra
J. David Gladstone Institutes
Co-authored papers 3
Siyuan Ding
Washington University School of Medicine
Co-authored papers 3
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 3
Toni M Schwarz
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Tom J Brett
Co-authored papers 2
Release 1.2